Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

This study has been completed.
Information provided by (Responsible Party):
SK Sharma, All India Institute of Medical Sciences, New Delhi Identifier:
First received: June 20, 2006
Last updated: April 25, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)